Invention Grant
- Patent Title: Method for diagnosing alzheimer's disease
-
Application No.: US14345179Application Date: 2012-09-17
-
Publication No.: US09606113B2Publication Date: 2017-03-28
- Inventor: Myriam Taverna , Romain Verpillot , Markus Otto , Hans Klafki
- Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) , Universite Paris-Sud 11
- Applicant Address: FR FR
- Assignee: Centre National De La Recherche Scientifique (C.N.R.S),Universite Paris-Sud 11
- Current Assignee: Centre National De La Recherche Scientifique (C.N.R.S),Universite Paris-Sud 11
- Current Assignee Address: FR FR
- Agency: Polster Lieder
- Priority: EP11306171 20110916
- International Application: PCT/EP2012/068268 WO 20120917
- International Announcement: WO2013/038014 WO 20130321
- Main IPC: G01N33/543
- IPC: G01N33/543 ; G01N33/68
Abstract:
The present invention relates to a method for diagnosing a neurodegenerative disease in a subject, wherein the level of each of at least two catecholamines is measured in a sample of biological fluid from said subject.
Public/Granted literature
- US20140370529A1 METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE Public/Granted day:2014-12-18
Information query
IPC分类:
